The IsoPSA test is intended to help assess whether patients with elevated PSA levels should go on to receive a biopsy ...
The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...
The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...
MedPage Today on MSN
FDA OKs Blood-Based Test to Help Detect High-Grade Prostate Tumors
The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced.
Diagnosed with prostate cancer at just 42, CEO Tamas Szabo feared he wouldn't see his children grow up. Now he's fighting to ...
Chimeric antigen receptor (CAR) T-cell therapy can cure certain types of blood cancer, but cost and a general lack of ...
The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...
The COVID-19 Treatment QuickStart Consortium worked with governments in seven low- and middle-income countries (LMICs), Ghana ...
Canadian research suggests recommendations against screening for prostate cancer has led to a rise in the rates of stage 4 ...
However, the UK National Screening Committee (UKNSC) has announced its draft decision to advise the government against ...
Edinburgh News on MSNOpinion
Limiting use of prostate cancer screening in men is a false move - Steve Cardownie
The UK National Steering Committee, which advises the Government, has decided that there is no need for a screening programme ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback